Early diagnostic solution for monitoring chemotherapy effectiveness in lung cancer patients at an initial treatment stage. Uses glycan analysis to predict treatment response and enable timely clinical decision-making.
Manufactured by
Veszprém, Hungary
CheMOnitor Ltd. is a medical device manufacturer that has developed the first early diagnostic solution designed to monitor the effectiveness of chemotherapy in lung cancer patients. The company focuses on providing early-stage monitoring capabilities to assess chemotherapy treatment outcomes for improved patient care.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangsu Avatarget Biotechnology Limited Liability Company
China · 1 relevant product
iPASY Technologies Kft
Hungary · 2 relevant products
Burning Rock Dx Co. Ltd.
China · 4 relevant products
Qingdao Raisecare Biological Technology Co., Ltd.
China · 1 relevant product
Glycanostics, s.r.o.
Slovakia · 5 relevant products
PHC Corporation
Japan · 1 relevant product
Biopsense Oy
Finland · 1 relevant product
APPOLON BIOTECK SAS
France · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
TrustBio Corporation
Taiwan · 1 relevant product
40 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 82 closest product alternatives
Jiangsu Avatarget Biotechnology Limited Liability Company · China
Clinical service for personalized cancer drug response evaluation using patient-derived tumor organoids and organ chips. Supports precision medicine treatment selection and optimization.
iPASY Technologies Kft · Hungary
Non-invasive urine-based diagnostic test that analyzes asparagine-linked carbohydrates of PSA to detect prostate cancer and assess disease aggressiveness. The assay provides comprehensive N-glycomic profiling in a single test, reducing false positives and unnecessary clinical interventions.
Burning Rock Dx Co. Ltd. · China
Sensitive detection of epidermal growth factor receptor mutations in lung cancer specimens. Identifies patients eligible for targeted tyrosine kinase inhibitor therapy.
Qingdao Raisecare Biological Technology Co., Ltd. · China
Advanced diagnostic test for measuring and analyzing immunological biomarkers in patient samples. Supports precise immune assessment to enable targeted therapeutic pathways and improved clinical outcomes.
Glycanostics, s.r.o. · Slovakia
Early-stage prostate cancer diagnostic test utilizing advanced glycan analysis for highly accurate detection. Designed to identify prostate cancer at initial stages, enabling timely clinical intervention and improved patient outcomes.
Glycanostics, s.r.o. · Slovakia
Non-invasive liquid biopsy test for early-stage prostate cancer detection using glycan analysis in blood serum. Achieves up to 90% accuracy using magnetic particle-based technology with minimal blood sample requirement of 10 microliters.
PHC Corporation · Japan
Laboratory testing services specializing in cancer detection and identification through tissue analysis and biomarker assessment. These services support early detection and treatment planning for cancer patients.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
APPOLON BIOTECK SAS · France
In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Glycanostics, s.r.o. · Slovakia
A non-invasive liquid biopsy diagnostic test for early-stage prostate cancer detection based on glycan analysis in blood serum. The test uses antibody-coated magnetic particles to detect cancer biomarkers from a minimal blood sample (10 µL or less than a single blood drop) with up to 90% accuracy. It is organ-specific, compatible with standard ELISA-based equipment and automated diagnostic systems, and designed to separate healthy men from those at risk of prostate cancer who require confirmatory biopsy, thereby reducing unnecessary biopsies.
TrustBio Corporation · Taiwan
Molecular diagnostic tools for oncology applications. Supports precision diagnostics for cancer-related molecular analysis.
70 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products